Search Results - "Hueman, Matthew T."

Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning by Yang, Charles Q, Wang, Huan, Liu, Zhenqiu, Hueman, Matthew T, Bhaskaran, Aadya, Henson, Donald E, Sheng, Li, Chen, Dechang

“…Integrating additional factors into the TNM staging system is needed for more accurate risk classification and survival prediction for patients with cutaneous…”
Get full text

Creating Prognostic Systems for Well-Differentiated Thyroid Cancer Using Machine Learning by Yang, Charles Q, Gardiner, Lauren, Wang, Huan, Hueman, Matthew T, Chen, Dechang

“…Updates to staging models are needed to reflect a greater understanding of tumor behavior and clinical outcomes for well-differentiated thyroid carcinomas. We…”
Get full text

Nonsteroidal anti-inflammatory drugs may affect cytokine response and benefit healing of combat-related extremity wounds by Lisboa, Felipe A., MD, Bradley, Matthew J., MD, Hueman, Matthew T., MD, Schobel, Seth A., PhD, Gaucher, Beverly J., PhD, Styrmisdottir, Edda L., MSc, Potter, Benjamin K., MD, Forsberg, Jonathan A., MD, PhD, Elster, Eric A., MD

“…Background After adequate operative debridement and antimicrobial therapies, combat-related extremity wounds that either heal or fail are both associated with…”
Get full text

Clinical Readiness Program: Refocusing the Military Health System by Holt, Danielle B, Hueman, Matthew T, Jaffin, Jonathan, Sanchez, Michael, Hamilton, Mark A, Mabry, Charles D, Bailey, Jeffrey A, Elster, Eric A

“…ABSTRACT Introduction The Military Health System serves to globally provide health services and trained medical forces. Military providers possess variable…”
Get full text

Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 by Peoples, George E, Holmes, Jarrod P, Hueman, Matthew T, Mittendorf, Elizabeth A, Amin, Asna, Khoo, Steven, Dehqanzada, Zia A, Gurney, Jennifer M, Woll, Michael M, Ryan, Gayle B, Storrer, Catherine E, Craig, Dianna, Ioannides, Constantin G, Ponniah, Sathibalan

“…Purpose: E75 is an immunogenic peptide from the HER2/ neu protein, which is overexpressed in many breast cancer patients. We have conducted two overlapping E75…”
Get full text

The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02 by BENAVIDES, Linda C, GATES, Jeremy D, PEOPLES, George E, CARMICHAEL, Mark G, PATEL, Ritesh, HOLMES, Jarrod P, HUEMAN, Matthew T, MITTENDORF, Elizabeth A, CRAIG, Dianna, STOJADINOVIC, Alexander, PONNIAH, Sathibalan

“…Purpose: HER2/ neu , a source of immunogenic peptides, is expressed in >75% of breast cancer patients. We have conducted clinical trials with the HER2/ neu E75…”
Get full text

Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients by PEOPLES, George E, GURNEY, Jennifer M, HUEMAN, Matthew T, WOLL, Mike M, RYAN, Gayle B, STORRER, Catherine E, FISHER, Christine, SHRIVER, Craig D, IOANNIDES, Constantin G, PONNIAH, Sathibalan

“…E75 is an immunogenic peptide from the HER2/neu protein that is highly expressed in breast cancer. We are conducting a clinical trial of an E75 +…”
Get full text

Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neu Peptide (AE37) Vaccine by HOLMES, Jarrod P, BENAVIDES, Linda C, PONNIAH, Sathibalan, PEOPLES, George E, GATES, Jeremy D, CARMICHAEL, Mark G, HUEMAN, Matthew T, MITTENDORF, Elizabeth A, MURRAY, James L, AMIN, Asna, CRAIG, Dianna, VON HOFE, Eric

“…HER-2/neu is overexpressed in breast cancer and is the source of immunogenic peptides. CD4(+) T-helper peptides for HER-2/neu are being evaluated in vaccine…”
Get full text

Management of Gastrointestinal Stromal Tumors by Hueman, Matthew T., MD, Schulick, Richard D., MD

“…A gastrointestinal stromal tumor (GIST) is a rare mesenchymal malignancy of the gastrointestinal (GI) tract. Malignant GISTs were first defined as a separate…”
Get full text

Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/ neu -Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial by Patil, Ritesh, MD, Clifton, Guy T., MD, Holmes, Jarrod P., MD, Amin, Asna, MD, Carmichael, Mark G., MD, Gates, Jeremy D., MD, Benavides, Linda H., MD, Hueman, Matthew T., MD, Ponniah, Sathibalan, PhD, Peoples, George E., MD, FACS

“…Background We have treated disease-free breast cancer patients with an HER2/ neu -derived peptide, E75, as an adjuvant vaccine. E75 was originally described as…”
Get full text

Management of Retroperitoneal Sarcomas by Hueman, Matthew T., MD, Herman, Joseph M., MD, MSc, Ahuja, Nita, MD

“…Retroperitoneal sarcomas present a therapeutic challenge based on their location, extent of invasion at diagnosis, and propensity for local recurrence…”
Get full text

Phase I Clinical Trial of a HER-2/neu Peptide (E75) Vaccine for the Prevention of Prostate-Specific Antigen Recurrence in High-Risk Prostate Cancer Patients by HUEMAN, Matthew T, DEHQANZADA, Zia A, PONNIAH, Sathibalan, PEOPLES, George E, NOVAK, Thomas E, GURNEY, Jennifer M, WOLL, Michael M, RYAN, Gayle B, STORRER, Catherine E, FISHER, Christine, MCLEOD, David G, IOANNIDES, Constantine G

“…Purpose: The E75 peptide is an immunogenic peptide from the HER-2/ neu protein that is substantially expressed in prostate cancer. We are conducting a clinical…”
Get full text

ASO Author Reflections: Mitigating Survival Disparities in African American Women with Breast Cancer within the US Military Healthcare System—The Impact of Equivalent Care by Hueman, Matthew T., Shriver, Craig D., Ellsworth, Rachel E.

Get full text

Evolving Treatment Strategies for Gallbladder Cancer by Hueman, Matthew T., Vollmer, Charles M., Pawlik, Timothy M.

“…Gallbladder cancer is an uncommon cancer that has traditionally been associated with a poor prognosis. In the era of laparoscopic cholecystectomy, incidental…”
Get full text

Management of Extremity Soft Tissue Sarcomas by Hueman, Matthew T., MD, Thornton, Katherine, MD, Herman, Joseph M., MD, MSc, Ahuja, Nita, MD

“…This article provides an understanding of the evaluation, staging, and management of patients with extremity soft tissue sarcoma. Although there are…”
Get full text

Correlations between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and HER-2/neu Vaccine-Related Immunity in Breast Cancer Patients by DEHQANZADA, Zia A, STORRER, Catherine E, HUEMAN, Matthew T, FOLEY, Rebecca J, HARRIS, Katie A, JAMA, Yusuf H, KAO, Tzu-Cheg, SHRIVER, Craig D, PONNIAH, Sathibalan, PEOPLES, George E

“…Purpose: We studied serum monocyte chemotactic protein-1 (MCP-1) levels in breast cancer patients in relationship to their clinicopathologic variables and…”
Get full text

Longterm Followup Assessment of a HER2/ neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients by Gates, Jeremy D., MD, Carmichael, Mark G., MD, Benavides, Linda C., MD, Holmes, Jarrod P., MD, Hueman, Matthew T., MD, Woll, Michael M., MD, Ioannides, Constantine G., PhD, Robson, Craig H., MD, McLeod, David G., MD, Ponniah, Sathibalan, MD, Peoples, George E., MD

“…Background E75 is an immunogenic peptide from the HER2/ neu protein that is expressed in prostate cancer. High-risk prostate cancer (HRPC) patients…”
Get full text

Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital by Lovejoy, Leann A., Eaglehouse, Yvonne L., Hueman, Matthew T., Mostoller, Bradley J., Shriver, Craig D., Ellsworth, Rachel E.

“…Background Survival disparities between African American women (AAW) and European American women (EAW) with invasive breast cancer may be attributable, in…”
Get full text

An algorithm for expanding the TNM staging system by Chen, Dechang, Hueman, Matthew T, Henson, Donald E, Schwartz, Arnold M

“…We describe a new method to expand the tumor, lymph node, metastasis (TNM) staging system using a clustering algorithm. Cases of breast cancer were used for…”
Get full text

Evolving Treatment Strategies for Gallbladder Cancer by Hueman, Matthew T., Vollmer, Charles M., Pawlik, Timothy M.

Get full text